España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Arcturus Therapeutics
ARCT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Arcturus Therapeutics (ARCT) Forecast
News
Earnings
Arcturus Therapeutics (ARCT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Arcturus Therapeutics (NASDAQ:ARCT) Stock
Arcturus Therapeutics Stock (NASDAQ: ARCT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
HC Wainwright & Co. Reiterates Buy on Arcturu...
Benzinga Newsdesk
Monday, December 16, 2024
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Thursday, November 14, 2024
Meiji Seika Pharma Invests In ARCALIS, Expect...
Benzinga Newsdesk
Monday, November 11, 2024
Arcturus Therapeutics Receives FDA Clearance ...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Arcturu...
Benzinga Newsdesk
Thursday, November 07, 2024
Arcturus Therapeutics Q3 2024 GAAP EPS $(0.26...
Benzinga Newsdesk
Tuesday, October 01, 2024
Unveiling 3 Analyst Insights On Arcturus Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Arcturu...
Benzinga Newsdesk
Monday, September 30, 2024
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Vandana Singh
Arcturus Therapeutics And CSL Announce Result...
Benzinga Newsdesk
Friday, September 13, 2024
Arcturus Therapeutics'Announces Japan's Minis...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Tuesday, September 03, 2024
Does Arcturus Therapeutics Have the Potential to Rally 216.35% as Wall Street Analysts Expect?
Zacks
Arcturus Therapeutics Receives Clearance Of I...
Benzinga Newsdesk
Monday, August 19, 2024
AN2 Therapeutics Plunges 66% in a Month: Here's Why
Zacks
Monday, August 12, 2024
Leerink Partners Initiates Coverage On Arctur...
Benzinga Newsdesk
Thursday, August 08, 2024
HC Wainwright & Co. Maintains Buy on Arcturus...
Benzinga Newsdesk
Tuesday, August 06, 2024
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Monday, August 05, 2024
Arcturus Therapeutics Q2 2024 GAAP EPS $(0.64...
Benzinga Newsdesk
Tuesday, July 02, 2024
HC Wainwright & Co. Reiterates Buy on Arcturu...
Benzinga Newsdesk
Monday, July 01, 2024
Arcturus Therapeutics Provides Mid-Year Updat...
Benzinga Newsdesk
Wednesday, June 26, 2024
Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival
Benzinga Neuro
Thursday, June 13, 2024
Cathie Wood-Led Ark Invest Sells $1.5M Worth Of Robinhood Shares Amid Muted Bitcoin Market — Also Dumps Zoom Stock Worth $3.3M
Benzinga Neuro
Tuesday, June 11, 2024
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
Benzinga Neuro
Friday, June 07, 2024
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
Vandana Singh
Arcturus Therapeutics shares are trading lowe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Arcturus Therapeutics Presents Phase 1 Result...
Benzinga Newsdesk
Tuesday, May 28, 2024
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
Vandana Singh
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Market-Moving News for May 28th
Benzinga Newsdesk
Arcutus Therapeutics Holdings shares are trad...
Benzinga Newsdesk
Arcturus Therapeutics Reports Phase 1b Data f...
Benzinga Newsdesk
Wednesday, May 22, 2024
Achilles Therapeutics And Arcturus Therapeuti...
Benzinga Newsdesk
Monday, May 20, 2024
CSL and Arcturus Therapeutics Announce Nature...
Benzinga Newsdesk
Friday, May 10, 2024
Canaccord Genuity Maintains Buy on Arcturus T...
Benzinga Newsdesk
Thursday, May 09, 2024
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Shanthi Rexaline
Wednesday, May 08, 2024
Arcturus Therapeutics Q1 EPS $(1.00) Beats $(...
Benzinga Newsdesk
Wednesday, March 20, 2024
HC Wainwright & Co. Reiterates Buy on Arcturu...
Benzinga Newsdesk
Monday, March 11, 2024
The Analyst Verdict: Arcturus Therapeutics In The Eyes Of 4 Experts
Benzinga Insights
Canaccord Genuity Maintains Buy on Arcturus T...
Benzinga Newsdesk
Friday, March 08, 2024
HC Wainwright & Co. Reiterates Buy on Arcturu...
Benzinga Newsdesk
Thursday, March 07, 2024
Recap: Arcturus Therapeutics Q4 Earnings
Benzinga Insights
Arcturus Therapeutics Q4 2023 GAAP EPS $(0.32...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
Earnings Preview: Arcturus Therapeutics
Benzinga Insights
Thursday, February 22, 2024
Arcturus Therapeutics Receives Orphan Medicin...
Benzinga Newsdesk
Thursday, February 08, 2024
Citigroup Maintains Buy on Arcturus Therapeut...
Benzinga Newsdesk
Monday, February 05, 2024
Arcturus Therapeutics Announces New COVID-19 ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch